MediciNova, Inc. (MNOV)
NASDAQ: MNOV · Real-Time Price · USD
1.370
+0.010 (0.74%)
Mar 9, 2026, 3:28 PM EDT - Market open
MediciNova Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Revenue | 0.41 | - | 1 | - | 4.04 | |
| Cost of Revenue | 0.38 | - | - | - | - | |
| Gross Profit | 0.03 | - | 1 | - | 4.04 | |
| Selling, General & Admin | 6.16 | 5.48 | 5.24 | 5.48 | 5.72 | |
| Research & Development | 7.15 | 7.19 | 5.66 | 9.14 | 8.54 | |
| Operating Expenses | 13.31 | 12.68 | 10.9 | 14.63 | 14.25 | |
| Operating Income | -13.28 | -12.68 | -9.9 | -14.63 | -10.22 | |
| Interest & Investment Income | 1.3 | 1.67 | 1.83 | 0.81 | 0.14 | |
| Other Non Operating Income (Expenses) | -0.01 | -0.04 | -0.5 | -0.25 | -0.06 | |
| Pretax Income | -11.99 | -11.04 | -8.57 | -14.07 | -10.13 | |
| Income Tax Expense | 0.01 | 0.01 | 0 | 0 | 0 | |
| Net Income | -12 | -11.05 | -8.57 | -14.07 | -10.13 | |
| Net Income to Common | -12 | -11.05 | -8.57 | -14.07 | -10.13 | |
| Shares Outstanding (Basic) | 49 | 49 | 49 | 49 | 49 | |
| Shares Outstanding (Diluted) | 49 | 49 | 49 | 49 | 49 | |
| Shares Change (YoY) | 0.03% | - | 0.00% | 0.92% | 9.42% | |
| EPS (Basic) | -0.24 | -0.23 | -0.17 | -0.29 | -0.21 | |
| EPS (Diluted) | -0.24 | -0.23 | -0.17 | -0.29 | -0.21 | |
| Free Cash Flow | -9.81 | -10.64 | -7.45 | -12.92 | -9.41 | |
| Free Cash Flow Per Share | -0.20 | -0.22 | -0.15 | -0.26 | -0.19 | |
| Gross Margin | 7.58% | - | 100.00% | - | 100.00% | |
| Operating Margin | -3242.47% | - | -990.03% | - | -253.02% | |
| Profit Margin | -2928.78% | - | -857.15% | - | -251.00% | |
| Free Cash Flow Margin | -2395.41% | - | -745.23% | - | -233.07% | |
| EBITDA | -13.26 | -12.65 | -9.88 | -14.61 | -10.19 | |
| EBITDA Margin | - | - | - | - | -252.38% | |
| D&A For EBITDA | 0.02 | 0.02 | 0.02 | 0.02 | 0.03 | |
| EBIT | -13.28 | -12.68 | -9.9 | -14.63 | -10.22 | |
| EBIT Margin | - | - | - | - | -253.02% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.